Home/Filings/4/0000950170-24-124085
4//SEC Filing

Ciaramella Giuseppe 4

Accession 0000950170-24-124085

CIK 0001745999other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:10 PM ET

Size

5.1 KB

Accession

0000950170-24-124085

Insider Transaction Report

Form 4
Period: 2024-11-06
Transactions
  • Sale

    Common Stock

    2024-11-06$26.36/sh51,110$1,347,050109,150 total
Footnotes (2)
  • [F1]The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.00 to $26.98, inclusive. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

Beam Therapeutics Inc.

CIK 0001745999

Entity typeother

Related Parties

1
  • filerCIK 0001786322

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:10 PM ET
Size
5.1 KB